Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Henry Chrystyn & Federico Lavorini. (2020) The dry powder inhaler features of the Easyhaler that benefit the management of patients. Expert Review of Respiratory Medicine 14:4, pages 345-351.
Read now
Read now
Katayoun Bahadori, Bradley S Quon, Mary M Doyle-Waters, Carlo Marra & J Mark FitzGerald. (2010) A systematic review of economic evaluations of therapy in asthma. Journal of Asthma and Allergy 3, pages 33-42.
Read now
Read now
David Hodgson, Kevin Mortimer & Tim Harrison. (2010) Budesonide/formoterol in the treatment of asthma. Expert Review of Respiratory Medicine 4:5, pages 557-566.
Read now
Read now
Ronald J. Halbert, David G. Tinkelman, Denise R. Globe & Shao-Lee Lin. (2009) Measuring Asthma Control Is the First Step to Patient Management: A Literature Review. Journal of Asthma 46:7, pages 659-664.
Read now
Read now
David MG Halpin. (2008) Symbicort: a pharmacoeconomic review. Journal of Medical Economics 11:2, pages 345-362.
Read now
Read now
Olof Selroos. (2007) A smarter way to manage asthma with a combination of a long-acting β2-agonist and inhaled corticosteroid. Therapeutics and Clinical Risk Management 3:2, pages 349-359.
Read now
Read now
Articles from other publishers (41)
Nicolas Roche, Arzu Yorgancıoğlu, Alvaro A. Cruz, Gabriel Garcia, Kim L. Lavoie, P.G. Abhijith, Manish Verma, Anurita Majumdar & Swarnendu Chatterjee. (2023) Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting β2-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance and reliever therapy. Respiratory Medicine, pages 107478.
Crossref
Crossref
Serafeim-Chrysovalantis Kotoulas, Ioanna Tsiouprou, Kalliopi Domvri, Polyxeni Dontsi, Athanasia Pataka & Konstantinos Porpodis. (2023) Open and Closed Triple Inhaler Therapy in Patients with Uncontrolled Asthma. Advances in Respiratory Medicine 91:4, pages 288-300.
Crossref
Crossref
Zarir Farokh Udwadia & Lancelot Mark Pinto. (2022) LABAs and Asthma: From the SMART Study to the SMART Approach. The Indian Journal of Chest Diseases and Allied Sciences 52:4, pages 191-193.
Crossref
Crossref
Hyung Jun Park, Jin-Young Huh, Ji Sung Lee, Jae Seung Lee, Yeon-Mok Oh & Sei Won Lee. (2022) Comparative efficacy of inhalers in mild-to-moderate asthma: systematic review and network meta-analysis. Scientific Reports 12:1.
Crossref
Crossref
Paola Rogliani, Beatrice Ludovica Ritondo, Josuel Ora, Mario Cazzola & Luigino Calzetta. (2020) SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis. European Respiratory Journal 56:3, pages 2000625.
Crossref
Crossref
Richard Beasley, James Harper, Grace Bird, Harriette Dunphy, Alex Semprini, Ian D. Pavord, Alberto Papi & Mark Weatherall. (2019) Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma. BMC Pulmonary Medicine 19:1.
Crossref
Crossref
Sadia Janjua, Stefanie Schmidt, Montse Ferrer & Christopher J Cates. (2019) Inhaled steroids with and without regular formoterol for asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Amaury Desjardin & Gilles Garcia. (2019) Nouvelles modalités de prescription des corticoïdes inhalés dans l’asthme léger à modéré. La Presse Médicale 48:3, pages 293-302.
Crossref
Crossref
Ryosuke Souma, Kumiya Sugiyama, Hiroyuki Masuda, Hajime Arifuku, Kentaro Nakano, Hiroyoshi Watanabe, Tomoshige Wakayama, Shingo Tokita, Masamitsu Tatewaki, Hideyuki Satoh, Kenya Koyama, Yumeko Hayashi, Fumiya Fukushima, Hirokuni Hirata, Masafumi Arima, Kazuhiro Kurasawa, Takeshi Fukuda & Yasutsugu Fukushima. (2018) Effect of adjusting the combination of budesonide/formoterol on the alleviation of asthma symptoms. Asthma Research and Practice 4:1.
Crossref
Crossref
Carlos E. Rodriguez-Martinez, Monica P. Sossa-Briceño & Jose A. Castro-Rodriguez. (2018) Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review. PharmacoEconomics 36:10, pages 1165-1200.
Crossref
Crossref
Yang Xia, Lexin Xia & Huahao Shen. (2018) SMART in the Management of Patients With Persistent Asthma. JAMA 320:9, pages 933.
Crossref
Crossref
Ritesh Agarwal, Sahajal Dhooria, AshutoshNath Aggarwal, VenkataN Maturu, InderpaulS Sehgal, Valliappan Muthu, KuruswamyT Prasad, LakshmikantB Yenge, Navneet Singh, Digambar Behera, SurinderK Jindal, Dheeraj Gupta, Thanagakunam Balamugesh, Ashish Bhalla, Dhruva Chaudhry, SunilK Chhabra, Ramesh Chokhani, Vishal Chopra, DevendraS Dadhwal, George D′Souza, Mandeep Garg, ShailendraN Gaur, Bharat Gopal, AlokeG Ghoshal, Randeep Guleria, KrishnaB Gupta, Indranil Haldar, Sanjay Jain, NirmalK Jain, VikramK Jain, AshokK Janmeja, Surya Kant, Surender Kashyap, GopiC Khilnani, Jai Kishan, Raj Kumar, ParvaizA Koul, Ashok Mahashur, AmitK Mandal, Samir Malhotra, Sabir Mohammed, PrasantaR Mohapatra, Dharmesh Patel, Rajendra Prasad, Pallab Ray, JaiK Samaria, PotsangbamSarat Singh, Honey Sawhney, Nusrat Shafiq, Navneet Sharma, Updesh PalS Sidhu, Rupak Singla, JagdishC Suri, Deepak Talwar & Subhash Varma. (2015) Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. Lung India 32:7, pages 3.
Crossref
Crossref
P. J. Barnes, T. B. Casale, R. Dahl, I. D. Pavord & M. E. Wechsler. (2014) The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use. Allergy 69:9, pages 1119-1140.
Crossref
Crossref
Kayleigh M Kew, Charlotta Karner, Stephanie M Mindus & Giovanni Ferrara. (2013) Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2013:12.
Crossref
Crossref
Kayleigh M Kew, Chris Mavergames & Julia AE Walters. (2013)
Long-acting beta
2
-agonists for chronic obstructive pulmonary disease
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Christopher J Cates, Roman Jaeschke, Stefanie Schmidt & Montse Ferrer. (2013) Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Christopher J Cates & Charlotta Karner. (2013) Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database of Systematic Reviews 2016:7.
Crossref
Crossref
Christopher J Cates, Roman Jaeschke, Stefanie Schmidt & Montse Ferrer. (2013) Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Bhupendrasinh F Chauhan, Caroline Chartrand & Francine M Ducharme. (2013) Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
TITO ATIENZA, TERESITA AQUINO, MARCELO FERNÁNDEZ, WATCHARA BOONSAWAT, MITSURU KAWAI, TAKAHIDE KUDO, Jan Ekelund, Stefan Ivanov & Lars-Goran Carlsson. (2013) Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: Phase III study results. Respirology 18:2, pages 354-363.
Crossref
Crossref
Bhupendrasinh F Chauhan, Caroline Chartrand & Francine M Ducharme. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Takefumi Saito & Tomoko Hasunuma. (2012) Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma. Clinical Drug Investigation 32:1, pages 51-61.
Crossref
Crossref
Fulvio Braido, Ilaria Baiardini, Enrico Compalati, Alberto Bordo & Giorgio W. Canonica. (2011) Towards the Grade of Recommendations, Assessment, Development and Evaluation system. Current Opinion in Allergy & Clinical Immunology 11:4, pages 361-374.
Crossref
Crossref
Carolina Cisneros, Joaquín Quiralte, Margarita Capel, Miguel Ángel Casado & Carl Mellstrom. (2013) Análisis coste-efectividad de budesonida/formoterol en el tratamiento de mantenimiento y a demanda (Symbicort SMART®) frente a salmeterol/fluticasona más terbutalina, en el tratamiento del asma persistente en España. PharmacoEconomics Spanish Research Articles 7:4, pages 163-175.
Crossref
Crossref
Christopher J Cates, Toby J Lasserson & Roman Jaeschke. (2010) Cochrane review: Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Evidence-Based Child Health: A Cochrane Review Journal 5:3, pages 1456-1542.
Crossref
Crossref
A. Vergnenègre, K. Atsou & C. Chouaïd. (2010) Pharmacoéconomie pour le pneumologue. EMC - Pneumologie 7:1, pages 1-15.
Crossref
Crossref
R. Louis, G. Joos, A. Michils & G. Vandenhoven. (2009) A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. International Journal of Clinical Practice 63:10, pages 1479-1488.
Crossref
Crossref
Lucas M. A. Goossens, Roland A. Riemersma, Dirkje S. Postma, Thys van der Molen & Maureen P. M. H. Rutten-van Mölken. (2009) An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice. Advances in Therapy 26:9, pages 872-885.
Crossref
Crossref
Helen K. Reddel, D. Robin Taylor, Eric D. Bateman, Louis-Philippe Boulet, Homer A. Boushey, William W. Busse, Thomas B. Casale, Pascal Chanez, Paul L. Enright, Peter G. Gibson, Johan C. de Jongste, Huib A. M. Kerstjens, Stephen C. Lazarus, Mark L. Levy, Paul M. O'Byrne, Martyn R. Partridge, Ian D. Pavord, Malcolm R. Sears, Peter J. Sterk, Stuart W. Stoloff, Sean D. Sullivan, Stanley J. Szefler, Mike D. Thomas & Sally E. Wenzel. (2009) An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations. American Journal of Respiratory and Critical Care Medicine 180:1, pages 59-99.
Crossref
Crossref
Jannie Wickstrøm, Nanna Dam, Irena Malmberg, Brian Bekker Hansen & Peter Lange. (2009) Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark - Cost-effectiveness analysis based on five randomised controlled trials. The Clinical Respiratory Journal 3:3, pages 169-180.
Crossref
Crossref
Christopher J Cates, Toby J Lasserson & Roman Jaeschke. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Christopher J Cates & Toby J Lasserson. (2009)
Combination formoterol and inhaled steroid versus beta
2
-agonist as relief medication for chronic asthma in adults and children
. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Matthew Peters. (2009) Single-Inhaler Combination Therapy for Maintenance and Relief of Asthma. Drugs 69:2, pages 137-150.
Crossref
Crossref
Dirkje S. Postma, Huib A. M. Kerstjens & Nick H. T. ten Hacken. (2008) RETRACTED ARTICLE: Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all?. Naunyn-Schmiedeberg's Archives of Pharmacology 378:2, pages 203-215.
Crossref
Crossref
Piotr Kuna & Izabela Kuprys-Lipinska. (2008) Budesonide/formoterol for maintenance and reliever therapy: new quality in asthma management. Therapy 5:4, pages 495-512.
Crossref
Crossref
A. Vergnenègre, P. Godard, K. Atsou & C. Chouaïd. (2008) Les corticoïdes inhalés dans l’asthme : analyse médico-économique des essais cliniques. Revue des Maladies Respiratoires 25:4, pages 375-390.
Crossref
Crossref
J.A. Castillo Laita, J. De Benito Fernández, A. Escribano Montaner, M. Fernández Benítez, S. García de la Rubia, J. Garde Garde, L. García-Marcos, C. González Díaz, M. Ibero Iborra, M. Navarro Merino, C. Pardos Martínez, J. Pellegrini Belinchon, J. Sánchez Jiménez, J. Sanz Ortega & J.R. Villa Asensi. (2008) Consensus Statement on the Management of Paediatric Asthma. Update 2007. Allergologia et Immunopathologia 36:1, pages 31-52.
Crossref
Crossref
Milind P Sovani, Christopher I Whale, Janet Oborne, Sue Cooper, Kevin Mortimer, Tommy Ekström, Anne E Tattersfield & Timothy W Harrison. (2008) Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help?. British Journal of General Practice 58:546, pages 37-43.
Crossref
Crossref
K. Hofman & T. van der Molen. (2007) Bijwerkingen van inhalatiecorticosteroïden: consequenties voor de eerste lijn. Bijblijven 23:10, pages 12-19.
Crossref
Crossref
J.A. Castillo Laita, J. De Benito Fernández, A. Escribano Montaner, M. Fernández Benítez, S. García de la Rubia, J. Garde Garde, L. García-Marcos, C. González Díaz, M. Ibero Iborra, M. Navarro Merino, C. Pardos Martínez, J. Pellegrini Belinchon, J. Sánchez Jiménez, J. Sanz Ortega & J.R. Villa Asensi. (2007) Consenso sobre tratamiento del asma en pediatría. Anales de Pediatría 67:3, pages 253-273.
Crossref
Crossref
Paul L McCormack & Katherine A Lyseng-Williamson. (2007) Budesonide/Formoterol. Drugs 67:16, pages 2407-2431.
Crossref
Crossref